// App-Quantinova.ai

2376 : Changes of Hepatitis B Immune Status after Allogeneic Hematopoietic Stem Cell Transplantation in HBsAg Negative/Anti-Hbc Positive Patients: A Single Center Observational Study

Researchers

Presenter

  • Jinhua Ren

Principal Investigators

  • Dabing Chen

  • Rong Zheng

  • Yu Zhang

  • Jingjing Xu

  • Xiaofeng Luo

  • Zhihong Zheng

  • Zhizhe Chen

  • Jianda Hu

  • Ting Yang

Medical Centers

  • Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China

  • Fujian Medical University Union Hospital, Fuzhou, China

  • Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, Fujian, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Drug-induced liver injury

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Aplastic anemia

  • Hepatitis B

  • Lymphomas

  • Anemia

Biomarkers

  • Serum hepatitis B virus DNA

Drug/Treatment

  • Entecavir

  • Allopurinol

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved